What is the appropriate evaluation and management for a 60-year-old woman with an itchy maculopapular erythematous rash on the breast?

Immediate Diagnostic Workup Required: Bilateral Diagnostic Mammogram with Skin Biopsy

A 60-year-old woman with an itchy maculopapular erythematous rash on the breast requires urgent evaluation to exclude Paget's disease of the breast and inflammatory breast cancer (IBC), both of which can present with these symptoms and carry significant mortality if diagnosis is delayed. 1

Initial Evaluation Algorithm

Step 1: Obtain Bilateral Diagnostic Mammogram ± Ultrasound

• This is the mandatory first imaging step for any breast skin changes in a woman ≥30 years old 1
• Do not delay imaging even if the rash appears benign clinically
• The mammogram may be normal in Paget's disease (frequently occult on imaging) 1

Step 2: Proceed Based on BI-RADS Category

If BI-RADS 1-3 (Negative, Benign, or Probably Benign):

• Perform punch biopsy of the affected skin immediately 1
• Antibiotics may be given if infection is suspected, but must not delay biopsy 1
• The key pitfall here: normal imaging does NOT exclude malignancy when skin changes are present

If BI-RADS 4-5 (Suspicious or Highly Suggestive of Malignancy):

• Perform core needle biopsy (preferred) with or without punch biopsy 1
• Surgical excision is an alternative option

Critical Differential Diagnoses to Exclude

Paget's Disease of the Breast

• Presents with eczema-like changes, itching, bleeding, ulceration of nipple/areola 1, 2
• Characterized by neoplastic cells in the epidermis of nipple-areolar complex 1
• Diagnosis is often delayed due to confusion with benign dermatologic conditions 1
• Associated underlying breast cancer present in 80-90% of cases 2
• Requires full-thickness skin biopsy including epidermis 2

Inflammatory Breast Cancer (IBC)

• Rare but aggressive (1-6% of breast cancers) 1
• Clinical diagnosis requiring erythema and dermal edema (peau d'orange) of ≥1/3 of breast skin with palpable border 1
• While your patient's presentation is described as maculopapular rather than peau d'orange, IBC must still be considered

Management After Biopsy Results

If Benign Biopsy with Normal Imaging:

• Do not stop here - this combination does not exclude malignancy 1
• Reassess clinical-pathologic correlation
• Consider:
  • Breast MRI 1
  • Repeat biopsy 1
  • Consultation with breast specialist 1

If Malignant Biopsy:

• Immediate referral per breast cancer treatment guidelines 1
• If Paget's disease confirmed, obtain breast MRI to define extent and identify additional disease 2

Common Pitfalls to Avoid

1. Do not treat empirically as eczema or dermatitis without tissue diagnosis - Paget's disease is frequently misdiagnosed as benign dermatologic conditions 1, 2

2. Do not be reassured by normal mammogram - Pure Paget's disease is frequently occult on mammography 1

3. Do not delay biopsy for trial of topical steroids or antibiotics - While a short trial may be considered if clinical suspicion for malignancy is low, diagnostic evaluation should not be delayed 1

4. Do not assume benign biopsy excludes cancer - If clinical suspicion remains high despite benign pathology, pursue MRI, repeat biopsy, and specialist consultation 1

Strength of Evidence

The recommendations are based on NCCN Clinical Practice Guidelines (2018 version being the most recent provided) 1, which represent Category 2A evidence and expert consensus. These guidelines specifically address the evaluation of breast skin changes and emphasize that any unusual skin changes may represent serious disease requiring systematic evaluation. The algorithmic approach is consistent across multiple iterations of these guidelines, demonstrating consensus on this management strategy.

The 2018 guidelines 1 are more recent than the 2009 versions 3 and should take precedence, though the core recommendations remain unchanged, strengthening confidence in this approach.